WTO TRIPS Agreement Archives - Knowledge Ecology International

KEI Oral Statement for US ITC Investigation on COVID-19 and TRIPS Agreement Flexibilities

Posted on March 23, 2023 by Claire Cassedy

NOTE: KEI also submitted a 16-page in depth written submission to this investigation on March 20, 2023. The US International Trade Commission (ITC) will hold a hearing on March 29-30, 2023 on COVID–19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS… Continue Reading →

KEI filing in ITC investigation 332–596, on COVID–19 Diagnostics and Therapeutics:, 20 March 2023

Posted on March 20, 2023 by James Love

ITC-KEI-COVID-TRIPS-30March2023

KEI Briefing Note 2022:3 Selected differences between Article 30, 31 and 44 of the WTO TRIPS Agreement as regards non-voluntary use of patented inventions

Selected differences between Article 30, 31 and 44 of the WTO TRIPS Agreement as regards non-voluntary use of patented inventions KEI Briefing Note 2022:3 October 12, 2022 KEI-BN-2022-3-TRIPS-Differences-3articles

International landscape of molnupiravir patents

Posted on October 20, 2021 by Luis Gil Abinader

(For more resources, please see our page on molnupiravir.) KEI has built a dataset of patents related to molnupiravir based upon a study by Imran et al (2021), the Medicines Patent Pool (MPP) MedsPal database, and our own searches. Our… Continue Reading →

Bolivia seeks to import COVID-19 vaccines from Biolyse, if Canada grants them a compulsory license

Posted on May 11, 2021 by Luis Gil Abinader

Today the government of Bolivia and Biolyse, a company based in Canada, signed an agreement to acquire COVID-19 vaccines manufactured by the company, if Canada grants them a compulsory license. Biolyse is a manufacturer of cancer drugs with the potential… Continue Reading →

KEI Statement at WTO COVID-19 Vaccine Equity Event

Posted on April 16, 2021 by Claire Cassedy

On Wednesday April 14, 2021, the World Trade Organization hosted an event titled “COVID-19 and Vaccine Equity: What can the WTO contribute?” which featured three sessions concerning vaccine distribution, manufacturing, and looking forward at how the system could better address… Continue Reading →

KEI Letter to New WTO Director-General on COVID-19 Response

Posted on March 1, 2021 by Claire Cassedy

On March 1, 2021, Knowledge Ecology International (KEI) sent a letter to Dr. Ngozi Okonjo-Iweala, the new Director-General of the World Trade Organization (WTO) regarding the WTO’s COVID-19 response. In the letter, KEI urged Dr. Ngozi to fully step into… Continue Reading →

While a major victory for Australia and public health, the WTO Appellate Body failed to address the legal status of the Doha Declaration

Posted on June 15, 2020 by Luis Gil Abinader

On June 9, 2020, the World Trade Organization (WTO) Appellate Body circulated its reports relating to the Australia – Tobacco Plain Packaging cases. The reports issued the decision regarding the appeals brought by Honduras and the Dominican Republic against the… Continue Reading →

WIPO side event, December 6, 2018, on the Implications of Article 27.3(a) of the WTO TRIPS Agreement on the patentability of gene and cell-based therapies

Posted on November 30, 2018 by Thiru

DATE: Thursday, 6 December 2018 TIME: 1:30 PM to 3 PM VENUE: Room B CONVENER: Knowledge Ecology International (KEI) Knowledge Ecology International (KEI) cordially invites you to attend our side event during negotiations of the 29th Session of the Standing… Continue Reading →

US opposes safeguards in WIPO treaty for the blind that are included in ACTA, and Beijing treaty

I was in Geneva today, and was told by several delegates the US is opposing this language in the negotiating text (from the Annex) [Proposed Footnote: It is understood that Contracting Parties who are members of the World Trade Organization… Continue Reading →

Categories